Aegerion Pharmaceuticals plans to conduct clinical development activities to support a marketing authorization application for lomitapide in HoFH in Japan and in support of our planned clinical study of lomitapide in pediatric and adolescent HoFH patients.
If you would like more information about a trial or want to enroll in a trial, please visit www.clinicaltrials.gov. This government-sponsored Web site lists most ongoing trials including those for which enrollment is currently taking place. Information is searchable by company, by drug candidate, by specific indication and by disease area. For each trial, the investigator is named and enrollment information is provided if appropriate.